Skip to content
★ Sign in to follow
SW

Steven W. King

Board Director
Director
Oncotelic Therapeutics, Inc.Avid Bioservices, Inc.Mosaic ImmunoEngineering Inc.
Total declarations
32
Companies
3
▲ Purchases (3 ops.)
€15k
▼ Sales (0 ops.)
—

Latest filing published 16 Jul 2021 for Oncotelic Therapeutics, Inc..

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Steven W. King: trading record in brief

Filings by Steven W. King span 3 companies, the busiest being Avid Bioservices, Inc., Mosaic ImmunoEngineering Inc. and Oncotelic Therapeutics, Inc. Over a trading history stretching from 15 February 2006 to 31 March 2021, the count stands at 32 filings.

The open-market record is one-sided, with 3 purchases worth €15k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 7 share grants and 1 option exercise.

In size, the median ticket on the buying side is €4,993.

The latest filing, published on 16 July 2021, reports a transaction in Oncotelic Therapeutics, Inc. The latest purchase dates back some time: it was published 5,889 days ago, on 24 September 2010. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Steven W. King

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations32 total

25 of 32 declarations